Cargando…
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785252/ https://www.ncbi.nlm.nih.gov/pubmed/35083184 http://dx.doi.org/10.3389/fped.2021.768438 |
_version_ | 1784638922096115712 |
---|---|
author | André, Pascal Diezi, Léonore Dao, Kim Crisinel, Pierre Alex Rothuizen, Laura E. Chtioui, Haithem Decosterd, Laurent Arthur Diezi, Manuel Asner, Sandra Buclin, Thierry |
author_facet | André, Pascal Diezi, Léonore Dao, Kim Crisinel, Pierre Alex Rothuizen, Laura E. Chtioui, Haithem Decosterd, Laurent Arthur Diezi, Manuel Asner, Sandra Buclin, Thierry |
author_sort | André, Pascal |
collection | PubMed |
description | Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is increasingly recognized in this population, and raises concern for unmet concentration targets. We conducted a retrospective evaluation of meropenem and piperacillin exposure in our hospital's pediatric hematology-oncology patients. Materials and Methods: We compared trough levels of meropenem and piperacillin in a cohort of unselected pediatric hematology-oncology patients stratified based on their estimated renal function as decreased, normal or with ARC, and on their neutrophil count. Results: Thirty-two children provided a total of 51 meropenem and 76 piperacillin samples. On standard intermittent intravenous regimen, 67% of all trough plasma concentrations were below targeted concentrations. In neutropenic children with bacterial infection, all meropenem and 60% of piperacillin levels were below target. Nearly two-thirds of total samples came from children with ARC. In these patients, antimicrobial exposure was insufficient in 85% of cases (compared to 36% in the decreased or normal renal function groups), despite a dosage sometimes exceeding the maximum recommended daily dose. Under continuous infusion of piperacillin, only 8% of plasma levels were insufficient. Discussion: Intermittent administration of meropenem and piperacillin often fails to ensure sufficient concentration exposure in children treated for malignancies, even at maximal recommended daily dosage. This can in part be attributed to ARC. We recommend thorough assessment of renal function, resolute dosage adjustment, continuous infusion whenever possible and systematic therapeutic drug monitoring. |
format | Online Article Text |
id | pubmed-8785252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87852522022-01-25 Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! André, Pascal Diezi, Léonore Dao, Kim Crisinel, Pierre Alex Rothuizen, Laura E. Chtioui, Haithem Decosterd, Laurent Arthur Diezi, Manuel Asner, Sandra Buclin, Thierry Front Pediatr Pediatrics Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is increasingly recognized in this population, and raises concern for unmet concentration targets. We conducted a retrospective evaluation of meropenem and piperacillin exposure in our hospital's pediatric hematology-oncology patients. Materials and Methods: We compared trough levels of meropenem and piperacillin in a cohort of unselected pediatric hematology-oncology patients stratified based on their estimated renal function as decreased, normal or with ARC, and on their neutrophil count. Results: Thirty-two children provided a total of 51 meropenem and 76 piperacillin samples. On standard intermittent intravenous regimen, 67% of all trough plasma concentrations were below targeted concentrations. In neutropenic children with bacterial infection, all meropenem and 60% of piperacillin levels were below target. Nearly two-thirds of total samples came from children with ARC. In these patients, antimicrobial exposure was insufficient in 85% of cases (compared to 36% in the decreased or normal renal function groups), despite a dosage sometimes exceeding the maximum recommended daily dose. Under continuous infusion of piperacillin, only 8% of plasma levels were insufficient. Discussion: Intermittent administration of meropenem and piperacillin often fails to ensure sufficient concentration exposure in children treated for malignancies, even at maximal recommended daily dosage. This can in part be attributed to ARC. We recommend thorough assessment of renal function, resolute dosage adjustment, continuous infusion whenever possible and systematic therapeutic drug monitoring. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8785252/ /pubmed/35083184 http://dx.doi.org/10.3389/fped.2021.768438 Text en Copyright © 2022 André, Diezi, Dao, Crisinel, Rothuizen, Chtioui, Decosterd, Diezi, Asner and Buclin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics André, Pascal Diezi, Léonore Dao, Kim Crisinel, Pierre Alex Rothuizen, Laura E. Chtioui, Haithem Decosterd, Laurent Arthur Diezi, Manuel Asner, Sandra Buclin, Thierry Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title | Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title_full | Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title_fullStr | Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title_full_unstemmed | Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title_short | Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! |
title_sort | ensuring sufficient trough plasma concentrations for broad-spectrum beta-lactam antibiotics in children with malignancies: beware of augmented renal clearance! |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785252/ https://www.ncbi.nlm.nih.gov/pubmed/35083184 http://dx.doi.org/10.3389/fped.2021.768438 |
work_keys_str_mv | AT andrepascal ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT diezileonore ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT daokim ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT crisinelpierrealex ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT rothuizenlaurae ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT chtiouihaithem ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT decosterdlaurentarthur ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT diezimanuel ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT asnersandra ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance AT buclinthierry ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance |